Dr. M. Mulder de

De heer de Mulder neemt met ingang van 12 april 2021 waar in de vakgroep cardiologie

Aandachtsgebied

  • Algemene cardiologie
  • pacemakers
  • ICD’s
  • hartfalen

Werkervaring

2018 – 2021 Amphia ziekenhuis, Breda

Opleiding

  • 2006   Geneeskunde aan de Universiteit van Amsterdam
  • 2018   Specialisatie tot cardioloog aan de Erasmus Universiteit Rotterdam 

Promotieonderzoek
2013: Glucose regulation in acute coronary syndromes; Implications for Outcome and Outcome Prediction

Aanwezig
Maandag t/m donderdag

Publicaties

  • de Mulder M, van Gameren M, van Asperen EA, Meuwissen M. Case report: Adenosine Triggered Myocardial Infarction During Myocardial Perfusion Stresstest Imaging in a Diabetic Patient Eur Heart J CR. 2021 Accepted for publication
  • Oemrawsingh RM, Akkerhuis KM, de Mulder M, Umans VA, Kietselaer B, Schotborgh C, et al High-Frequency Biomarker
  • Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary
  • Syndrome. Circulation. 2019 Jan 2;139(1):134-136.
  • Van den Berg VJ, Umans VA, Stam F, de Mulder M, Akkerhuis KM, Cornel JH et al. Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome. Circulation. 2016 Sep 27;134(13):984-6.
  • de Mulder M, Hendriksz TR, de Jong PL, IJsselmuiden AJ. A curly case: dissecting giant arteriovenous anomaly – left main
  • coronary artery shunting to superior vena cava. EuroIntervention. 2015 Oct;11(6):e1.
  • de Mulder M, Umans VA, Boersma E. Intensive glucose control for acute myocardial infarction--reply. JAMA Intern Med. 2014 May;174(5):826-7.
  • de Mulder M, Umans VA, Cornel JH, van der Zant FM, Stam F, Oemrawsingh RM et al. Intensive glucose regulation in
  • hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary
  • syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med. 2013 Nov 11;173(20):1896-904.
  • de Mulder M, van der Ploeg T, de Waard GA, Boersma E, Umans VA. Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction. Cardiology. 2011;120(4):227-34.
  • de Waard GA, Jansen EK, de Mulder M, Vonk AB, Umans VA. Long-term outcomes of isolated aortic valve replacement and concomitant AVR and coronary artery bypass grafting. Neth Heart J. 2012 Mar;20(3):110-7
  • de Mulder M, Oemrawsingh RM, Stam F, Boersma E, Umans VA. Comparison of diagnostic criteria to detect undiagnosed
  • diabetes in hyperglycaemic patients with acute coronary syndrome. Heart. 2012 Jan;98(1):37-41.
  • de Mulder M, Umans VA, Stam F, Cornel JH, Oemrawsingh RM, Boersma E. Intensive management of hyperglycaemia in
  • acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial. Diabet Med. 2011 Oct;28(10):1168-75.
  • de Mulder M, van der Zant FM, Knaapen P, Cornel JH, Umans VA. Long-term Clinical Outcome and MIBI SPECT Parameters in Percutaneous Coronary Interventions. Neth Heart J. 2011 Feb;19(2):68-72.
  • de Mulder M, Gitt A, van Domburg R, Hochadel M, Seabra-Gomes R, Serruys PW et al. EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J. 2011 Jun;32(11):1398-408.
  • Wit MA, de Mulder M, Jansen EK, Umans VA. Diabetes mellitus and its impact on long-term outcomes after coronary
  • artery bypass graft surgery. Acta Diabetol. 2013 Apr;50(2):123-8. (Epub 2010)
  • de Mulder M, Cornel JH, van der Ploeg T, Boersma E, Umans VA. Elevated admission glucose is associated with increased
  • long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy.
  • Am Heart J. 2010 Sep;160(3):412-9.
  • de Mulder M, Broers CJ, Jansen EK, de Swart HB, Peels HO, Lieuw-A-Fa ML et al. Arterial end-to-side grafting in coronary
  • artery bypass grafting: the Tector procedure. Neth Heart J. 2010 Jan;18(1):7-11.
  • de Mulder M, Zwaan E, Wielinga Y, Stam F, Umans VA. How to implement a clinical pathway for intensive glucose regulation in acute coronary syndromes. Crit Pathw Cardiol. 2009 Jun;8(2):72-8.
  • de Mulder M, Oemrawsingh RM, Stam F, Boersma E, Umans VA. Current management of hyperglycemia in acute coronary syndromes: a national Dutch survey. Crit Pathw Cardiol. 2009 Jun;8(2):66-70.
  • Knaapen P, de Mulder M, van der Zant FM, Peels HO, Twisk JW, van Rossum AC et al. Infarct size in primary angioplasty
  • without on-site cardiac surgical backup versus transferal to a tertiary center: a single photon emission computed tomography study. Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):237-43.